Jasper Ridge Partners’s RAPT Therapeutics RAPT Stock Holding History

Jasper Ridge Partners’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,706	Closed	-$55.7K	–	149
2025 Q1	$55.7K	Hold	5,706	–	–	﹤0.01%	141
2024 Q4	$72.1K	Hold	5,706	–	–	﹤0.01%	139
2024 Q3	$91.8K	Hold	5,706	–	–	﹤0.01%	136
2024 Q2	$139K	Hold	5,706	–	–	﹤0.01%	135
2024 Q1	$410K	Hold	5,706	–	–	0.01%	109
2023 Q4	$1.13M	Hold	5,706	–	–	0.05%	83
2023 Q3	$759K	Hold	5,706	–	–	0.04%	87
2023 Q2	$854K	Hold	5,706	–	–	0.04%	85
2023 Q1	$838K	Hold	5,706	–	–	0.04%	90
2022 Q4	$904K	Hold	5,706	–	–	0.05%	82
2022 Q3	$1.1M	Hold	5,706	–	–	0.07%	79
2022 Q2	$833K	Hold	5,706	–	–	0.05%	88
2022 Q1	$1M	Hold	5,706	–	–	0.05%	86
2021 Q4	$1.68M	Hold	5,706	–	–	0.06%	82
2021 Q3	$1.42M	Buy	+5,706	New	+$1.51M	0.06%	93

Other funds holding RAPT

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return